Integral Derivatives’s MetLife MET Stock Holding History

Integral Derivatives’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-14,421	Closed	-$702K	–	1236
2017 Q2	$706K	Sell	14,421 -5,948	-29%	-$276K	0.01%	598
2017 Q1	$959K	Sell	20,369 -4,276	-17%	-$204K	0.02%	534
2016 Q4	$1.18M	Buy	24,645 +16,494	+202%	+$756K	0.02%	464
2016 Q3	$323K	Buy	+8,151	New	+$306K	0.01%	763
2016 Q1	–	Sell	-26,643	Closed	-$996K	–	1015
2015 Q4	$1.15M	Buy	+26,643	New	+$1.17M	0.03%	413
2015 Q3	–	Sell	-17,123	Closed	-$800K	–	1201
2015 Q2	$854K	Buy	17,123 +5,835	+52%	+$276K	0.02%	576
2015 Q1	$509K	Sell	11,288 -12,006	-52%	-$540K	0.01%	695
2014 Q4	$1.12M	Buy	23,294 +15,035	+182%	+$714K	0.02%	636
2014 Q3	$395K	Buy	+8,259	New	+$401K	0.01%	1038
2014 Q1	–	Sell	-8,483	Closed	-$390K	–	1492
2013 Q4	$408K	Buy	+8,483	New	+$380K	0.01%	1116

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Integral Derivatives's MET Position: Q3 2017 in Review

Integral Derivatives sold out of MetLife (MET) in Q3 2017, closing a stake of 14,421 shares — an estimated $702K sold.

Integral Derivatives first reported a position in MET in Q4 2013 and held it in 10 quarters. The position peaked at $1.18M in Q4 2016. 986 funds tracked by Wall St. Rank hold MET as of Q3 2017.

Integral Derivatives reported no remaining MetLife position as of Q3 2017 after selling out during the quarter.
Integral Derivatives sold 14,421 MetLife shares in Q3 2017, an estimated $702K.
Integral Derivatives first reported a position in MetLife in Q4 2013 and held it in 10 quarters.
Integral Derivatives's MetLife position peaked at $1.18M in Q4 2016.
986 funds tracked by Wall St. Rank held MetLife as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.